Analysts think PAVM stock price could increase by 350%
Aug 29, 2024, 6:25 AM
28.01%
What does PAVM do
PAVmed, a New York-based medical device company, specializes in medical technologies and employs 107 staff. Its subsidiaries include Lucid Diagnostics, offering cancer detection products, and Veris Health, focused on personalized cancer care.
5 analysts think PAVM stock price will increase by 350.23%. The current median analyst target is $4.08 compared to a current stock price of $0.91. The lowest analysts target is $4.04 and the highest analyst target is $23.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
